EW
55
5
EXPE
83
8
EXPD
29
2
FSLR
50
6
INTU
54
2
AEE
51
3
IR
46
3
CMCSA
49
3
IRM
33
5
UPS
51
6
PLD
35
5
VTR
44
4
CME
59
3
GRMN
53
3
ICE
53
5
LEN
21
3
M
40
3
ADBE
50
3
PSX
24
2
SPG
45
2
EW
55
5
EXPE
83
8
EXPD
29
2
FSLR
50
6
INTU
54
2
AEE
51
3
IR
46
3
CMCSA
49
3
IRM
33
5
UPS
51
6
PLD
35
5
VTR
44
4
CME
59
3
GRMN
53
3
ICE
53
5
LEN
21
3
M
40
3
ADBE
50
3
PSX
24
2
SPG
45
2
Financhill
Back

Alexandria Real Estate Equities Vs. Novo Nordisk AS Industry Stock Comparison

Sell
14

ARE
Alexandria Real Estate Equities

Last Price:
$99.23
Seasonality Move:
-0.04%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
14
Alexandria Real Estate Equities (ARE) is a Sell

Is Alexandria Real Estate Equities a Buy, Sell or Hold?

  • The current Alexandria Real Estate Equities [ARE] share price is $99.17. The Score for ARE is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • ARE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARE Stock Price Chart

What is Alexandria Real Estate Equities's stock price today?

  • The Alexandria Real Estate Equities share price today is $99.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARE is experiencing slight selling pressure.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

ARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.09 Sell
Relative Strength Index (14 RSI): 34.7 Sell
Chaikin Money Flow: -611556 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (101.24 - 109.02) Sell
Bollinger Bands (100): (107.39 - 120.43) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

ARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 100.85 Sell
20-day SMA: 105.14 Sell
50-day SMA: 109.96 Sell
200-day SMA: 117.24 Sell
8-day EMA: 100.69 Sell
20-day EMA: 103.83 Sell
50-day EMA: 108.46 Sell
200-day EMA: 115.29 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Alexandria Real Estate Equities Earnings Growth & ARE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $5.84 per share, and a decrease next year of $0.49 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

Alexandria Real Estate Equities Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):